Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 21, 2021; 27(35): 5890-5907
Published online Sep 21, 2021. doi: 10.3748/wjg.v27.i35.5890
Published online Sep 21, 2021. doi: 10.3748/wjg.v27.i35.5890
Common | Infrequent | Rare |
IBS-diarrhea | Small bowel bacterial overgrowth | Small bowel enteropathies (i.e. Whipple’s disease, tropical sprue, amyloid, etc.) |
Bile acid diarrhea | Mesenteric ischemia | Hypoparathyroidism |
Diet (artificial sweeteners, caffeine, FODMAP malabsorption, etc.) | Lymphoma | Addison’s disease |
Colonic neoplasia | Surgical causes (small bowel resection, incontinence, etc.) | Hormone secreting tumors (i.e. VIPoma, gastrinoma, carcinoid) |
IBD | Chronic pancreatitis | Autonomic neuropathy |
Celiac disease | Radiation enteropathy | Factitious diarrhea |
Drugs (antibiotics, NSAID, etc.) | Pancreatic carcinoma | Brainerd diarrhea |
Overflow diarrhea | Hyperthyroidism | |
Diabetes | ||
Chronic infections (i.e. giardiasis) | ||
Cystic fibrosis |
- Citation: Rossi RE, Elvevi A, Citterio D, Coppa J, Invernizzi P, Mazzaferro V, Massironi S. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. World J Gastroenterol 2021; 27(35): 5890-5907
- URL: https://www.wjgnet.com/1007-9327/full/v27/i35/5890.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i35.5890